Blood Draw Barriers for Treatment with Clozapine and Development of a Point-of-Care Monitoring Device

Abstract

Survey results demonstrate physicians' desire for point-of-care monitoring technology, particularly among younger prescribers. Prototype sensor results identify that CLZ can be detected and integrated for future device development. Future development will also include integration of WBCs for a complete detection device.